{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:38:47Z","timestamp":1781311127250,"version":"3.54.1"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>\n                    The global rise of antimicrobial resistance (AMR) in\n                    <jats:italic>Enterobacterales<\/jats:italic>\n                    , including the\n                    <jats:italic>Enterobacter cloacae<\/jats:italic>\n                    complex, is narrowing treatment options. Tigecycline, a last-resort antibiotic for the treatment of multidrug-resistant (MDR) Gram-negative pathogens, is increasingly compromised by emerging resistance mechanisms, notably efflux pump overexpression and regulatory network adaptation. In this study, sixty clinical isolates of\n                    <jats:italic>Enterobacter cloacae<\/jats:italic>\n                    (thirty-eight tigecycline-resistant [TGC-R], twenty-two tigecycline-susceptible [TGC-S]) were analyzed to investigate gene expression changes in efflux pumps and regulatory genes under tigecycline pressure (1\/2 minimum inhibitory concentration [MIC]) and standard conditions. Tigecycline exposure markedly increased\n                    <jats:italic>tolC<\/jats:italic>\n                    and\n                    <jats:italic>acrA<\/jats:italic>\n                    together with the regulators\n                    <jats:italic>marA<\/jats:italic>\n                    and\n                    <jats:italic>ramA<\/jats:italic>\n                    , while\n                    <jats:italic>acrB<\/jats:italic>\n                    increased only modestly. This indicates a strong regulatory component to the tigecycline response. In contrast, TGC-S isolates exhibited significant induction of\n                    <jats:italic>marA, marB<\/jats:italic>\n                    without corresponding activation of efflux pumps. \u0394log\n                    <jats:sub>2<\/jats:sub>\n                    FC analysis highlighted distinct transcriptional shifts between exposed and unexposed groups, with resistant strains displaying greater divergence. Heatmaps and boxplot visualizations, supported by Wilcoxon test statistics, underscored the regulatory responses associated with tigecycline pressure. These findings indicate that, alongside AcrAB-TolC upregulation, stress-responsive regulators (\n                    <jats:italic>marA<\/jats:italic>\n                    ,\n                    <jats:italic>ramA<\/jats:italic>\n                    ) are strongly induced by sub-inhibitory tigecycline, underscoring the multifactorial regulation of tigecycline response in the\n                    <jats:italic>E<\/jats:italic>\n                    .\n                    <jats:italic>cloacae<\/jats:italic>\n                    complex.\n                  <\/jats:p>","DOI":"10.3389\/fcimb.2026.1745642","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T07:04:41Z","timestamp":1772003081000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of sub-inhibitory tigecycline (\u00bd-MIC) on AcrAB-TolC and mar\/ram\/sox regulatory genes in Enterobacter cloacae complex isolates"],"prefix":"10.3389","volume":"16","author":[{"given":"Lukasz","family":"Korczak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Majewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawel","family":"Sacha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominika","family":"Chludzinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elzbieta","family":"Tryniszewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.3390\/microorganisms10101907","article-title":"Bacterial Infections among Patients with Chronic Diseases at a Tertiary Care Hospital in Saudi Arabia","volume":"10","author":"Bazaid","year":"2022","journal-title":"Microorganisms"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-55705-2","article-title":"Occurrence and mechanisms of tigecycline resistance in carbapenem- and colistin-resistant Klebsiella pneumoniae in Thailand","volume":"14","author":"Chirabhundhu","year":"2024","journal-title":"Sci. Rep."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1128\/AAC.46.4.1093-1097.2002","article-title":"mar operon involved in multidrug resistance of enterobacter aerogenes","volume":"46","author":"Chollet","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.00392","article-title":"Enterobacter aerogenes and Enterobacter cloacae; Versatile bacterial pathogens confronting antibiotic treatment","volume":"6","author":"Davin-Regli","year":"2015","journal-title":"Front. Microbiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.3390\/antibiotics10091117","article-title":"Clinical status of efflux resistance mechanisms in gram-negative bacteria","volume":"10","author":"Davin-Regli","year":"2021","journal-title":"Antibiotics"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00181-19","article-title":"Antimicrobial resistance in ESKAPE pathogens","volume":"33","author":"De Oliveira","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3390\/antibiotics9120855","article-title":"The role of efflux pumps in the transition from low-level to clinical antibiotic resistance","volume":"9","author":"Ebbensgaard","year":"2020","journal-title":"Antibiotics"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1111\/j.1751-7915.2008.00063.x","article-title":"Constitutive SoxS Expression in a Fluoroquinolone-Resistant Strain with a Truncated SoxR Protein and Identification of a New Member of the marA-soxS-rob Regulon, mdtG","volume":"54","author":"F\u00e0brega","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.3855\/jidc.15157","article-title":"Emergence of tigecycline-resistant Klebsiella pneumoniae ST11 clone in patients without exposure to tigecycline","volume":"15","author":"Goodarzi","year":"2021","journal-title":"J. Infect. Dev. Ctries."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e0119064","DOI":"10.1371\/journal.pone.0119064","article-title":"Tigecycline susceptibility and the role of efflux pumps in tigecycline resistance in KPC-producing klebsiella pneumoniae","volume":"10","author":"He","year":"2015","journal-title":"PloS One"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.00828","article-title":"MarA, ramA, and soxS as mediators of the stress response: survival at a cost","volume":"11","author":"Holden","year":"2020","journal-title":"Front. Microbiol."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkn311","article-title":"Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies","volume":"62","author":"Kelesidis","year":"2008","journal-title":"J. Antimicrobial Chemotherapy"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.03601-22","article-title":"Evaluation of dilution susceptibility testing methods for aztreonam in combination with avibactam against enterobacterales","volume":"10","author":"Kelley","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1289396","article-title":"Molecular mechanisms of tigecycline-resistance among Enterobacterales","volume":"14","author":"Korczak","year":"2024","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1126\/science.abl5997","article-title":"The post-antibiotic era is here","volume":"373","author":"Kwon","year":"2021","journal-title":"Science"},{"key":"B16","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1128\/cmr.00117-14","article-title":"The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria","volume":"28","author":"Li","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-019-0489-3","article-title":"The nature and epidemiology of OqxAB, a multidrug efflux pump","volume":"8","author":"Li","year":"2019","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1093\/jac\/dkz569","article-title":"Expression of AraC\/XylS stress response regulators in two distinct carbapenem-resistant Enterobacter cloacae ST89 biotypes","volume":"75","author":"Majewski","year":"2020","journal-title":"J. Antimicrobial Chemotherapy."},{"key":"B19","unstructured":"MIC determination of non-fastidious and fastidious organisms"},{"key":"B20","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.2147\/IDR.S199993","article-title":"Effects of sub-inhibitory concentrations of meropenem and tigecycline on the expression of genes regulating pili, efflux pumps and virulence factors involved in biofilm formation by Acinetobacter baumannii","volume":"12","author":"Navidifar","year":"2019","journal-title":"Infect. Drug Resist."},{"key":"B22","doi-asserted-by":"publisher","first-page":"5830","DOI":"10.1128\/AAC.04865-14","article-title":"Case-control study of the risk factors for acquisition of Pseudomonas and Proteus species during tigecycline therapy","volume":"59","author":"Park","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1128\/AAC.00072-07","article-title":"Cloning, nucleotide sequencing, and analysis of the acrAB-tolC efflux pump of enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate","volume":"51","author":"P\u00e9rez","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"B24","doi-asserted-by":"publisher","first-page":"6256","DOI":"10.1128\/aac.01085-12","article-title":"Effect of transcriptional activators SoxS, RobA, and RamA on expression of multidrug efflux pump AcrAB-TolC in Enterobacter cloacae","volume":"56","author":"P\u00e9rez","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"B25","doi-asserted-by":"publisher","first-page":"E45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.780201","article-title":"Subinhibitory concentrations of clinically-relevant antimicrobials affect resistance-nodulation-division family promoter activity in acinetobacter baumannii","volume":"12","author":"Prieto Martin Gil","year":"2021","journal-title":"Front. Microbiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ijantimicag.2010.09.009","article-title":"Risk factors and outcome of extended-spectrum \u03b2-lactamase-producing Enterobacter cloacae bloodstream infections","volume":"37","author":"Qureshi","year":"2011","journal-title":"Int. J. Antimicrob. Agents."},{"key":"B28","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.cmi.2022.10.018","article-title":"Antibiotic heteroresistance in ESKAPE pathogens, from bench to bedside","volume":"29","author":"Roch","year":"2023","journal-title":"Clin. Microbiol. Infect."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-015-0061-0","article-title":"Mechanisms of antimicrobial resistance in Gram-negative bacilli","volume":"5","author":"Rupp\u00e9","year":"2015","journal-title":"Ann. Intensive Care"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1128\/AAC.49.3.1017-1022.2005","article-title":"Influence of transcriptional activator ramA on expression of multidrug efflux pump acrAB and tigecycline susceptibility in klebsiella pneumoniae","volume":"49","author":"Ruzin","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01405-7","article-title":"The multiple antibiotic resistance operon of enteric bacteria controls DNA repair and outer membrane integrity","volume":"8","author":"Sharma","year":"2017","journal-title":"Nat. Commun."},{"key":"B32","volume-title":"Stata statistical software: release 17","year":"2021"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1128\/aac.01726-09","article-title":"Evaluation of Etest to determine tigecycline MICs for Enterobacter species","volume":"54","author":"Stuart","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"B34","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.bbrc.2014.05.090","article-title":"Bacterial multidrug efflux pumps: Mechanisms, physiology and pharmacological exploitations","volume":"453","author":"Sun","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2013.00053","article-title":"Effect of antimicrobial exposure on AcrAB expression in Salmonella enterica subspecies enterica serovar Choleraesuis","volume":"4","author":"Usui","year":"2013","journal-title":"Front. Microbiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1093\/jac\/dks530","article-title":"Genetic characterization of tigecycline resistance in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes","volume":"68","author":"Veleba","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"B37","doi-asserted-by":"publisher","first-page":"4466","DOI":"10.1128\/AAC.06224-11","article-title":"Tigecycline resistance can occur independently of the ramA gene in Klebsiella pneumoniae","volume":"56","author":"Veleba","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"B38","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/1574-6968.12182","article-title":"The 216-bp marB gene of the marRAB operon in Escherichia coli encodes a periplasmic protein which reduces the transcription rate of marA","volume":"345","author":"Vinu\u00e9","year":"2013","journal-title":"FEMS Microbiol. Lett."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1471469","article-title":"The tigecycline resistance mechanisms in Gram-negative bacilli","volume":"14","author":"Wang","year":"2024","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s10096-020-04121-1","article-title":"Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review","volume":"41","author":"Yaghoubi","year":"2022","journal-title":"Eur. J. Clin. Microbiol. Infect. Diseases."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115185","article-title":"First emergence of acrAB and oqxAB mediated tigecycline resistance in clinical isolates of Klebsiella pneumoniae pre-dating the use of tigecycline in a Chinese Hospital","volume":"9","author":"Zhong","year":"2014","journal-title":"PloS One"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1745642\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T07:04:44Z","timestamp":1772003084000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1745642\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":41,"alternative-id":["10.3389\/fcimb.2026.1745642"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1745642","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]},"article-number":"1745642"}}